In a review of 10 medications for female efficacy, 8 were pulled from the market because they presented too great a risk to female patients. Women's bodies metabolize drugs differently. We broke it all down in a report you can literally show your doc.

When doctors don’t believe women, lives are put at risk. Asterisk is making dismissal harder, and proper treatment faster, by putting your health data in your control. Subscribe to our Substack and share your story. .#WomensHealth #GenderDataGap

Blazing-fast image creation – using just your voice. Try Grok Imagine.

Two years. Twenty teammates. Two hundred thousand views on a single TikTok post. And now, a whitepaper. So proud of what we’re building. Read it here: #womenshealth

This Sat (6PM CEST) we celebrate 2 yrs of Asterisk! Join us on Zoom for tools to navigate dismissal, & real talk on women’s health. BONUS: early access to our alpha platform, a digital swag bag. RSVP: #WomensHealth

Come to ask questions. Come to discuss.

Hello whitepaper. 👀

We’re on tonight with a sneak peek of our WHITEPAPER come on down!.

RT @DeSciWorld:

#ADHD isn’t rare: it’s the most common neurodevelopmental disorder, impacting around 1.3B women worldwide. Our report breaks down why women are still underdiagnosed & undertreated. Read part 2 now. #WomenWithADHD #Neurodiversity.

Celebrate 2 yrs of Asterisk! Join us alongside our partners to help shape the future of #womenshealth research PLUS get a digital goodie bag from them!.RSVP now:

Nearly 1 in 2 women with #ADHD also have pre-menstrual dysphoric disorder (#PMDD), compared to just over 1 in 4 in neurotypical women. Part 2 of our #ADHDinWomen series explores why this overlap matters for diagnosis & care: .#WomensHealth

RT @vana: Women are up to 6x more likely to have an adverse reaction to drugs, because most medical research relies on data from men. @ast….

The numbers only tell part of the story. Behind them are years of misdiagnoses, untreated #ADHD, and the ripple effects it has on #womenshealth, safety, and economic security. Part 2 of ADHD series explores what happens when women are diagnosed later:.

84% of women report not being listened to or believed by a doctor at least once in their lifetimes. You're not alone, and you're not crazy. Join us on Aug 30th to learn why the gender data gap exists and what role Asterisk has to play. #womenshealth

Women with #ADHD are more likely to show inattentive symptoms rather than hyperactive ones, making them harder to spot and less likely to be referred for diagnosis. Part 2 of our #ADHDinWomen series dives into why so many slip through the cracks: .

When 94% of #ADHD referrals go to boys, girls don’t stand a chance. In Part 2 of our ADHD series, we unpack how the gender gap starts, and what it costs women in the long run. Read the article:..#ADHDinGirls #Neurodivergent

#ADHD has been studied for 200+ years. Women weren’t included until 50 years ago. That’s only 25% of the research timeline. Read Part 2 of our series + join Astra to change that:..#NeurodivergentWomen #WomensHealth

Our anniversary is coming up! We’re hosting a virtual event to discuss what’s happening in #womenshealth and how to use #DeSci to advocate for better care. You’re invited! Here’s the link to learn more and join:

Only 3 out of 10 #ADHD diagnostic tools include female-specific data. The rest? Built on male norms. No wonder women are so often missed. Read article 2 of 6 in our ADHD series to learn more:..#ADHDinWomen #Neurodivergence #HealthEquity

When #ADHD is misread as anxiety or depression, girls get sidelined. Part 2 of our ADHD series looks at why girls are often misdiagnosed, and how Astra is helping rewrite the data from the ground up. .#ADHD #ADHDWomen #HealthEquity #Neurodivergent